CORPORATE INFO FOR INVESTORS OUR PRODUCTS BUSINESS DEVELOPMENT CONTACT US HOME

Menu

Financial Statements
  • Financial Reports
  • Securities Filing
      
    Investor Resources
  • Fact Sheet
  • Presentations
  • Analyst Coverage
  • Calendar of Events
  • FAQ
  • Shareholder
         Services
  • Investor Kit
  • Investor Information

    News
  • Press Releases
  • Corporate News
  • Awards
    •   PRESS RELEASES  
    COMMUNIQUÉS DE PRESSE (Français)

    2007  |   2006  |   2005  |   2004  |   2003  |   2002  |   2001  |   2000  |   1999  |   1998  |   1997  |  


    November 6, 2008
    PALADIN REPORTS RECORD THIRD QUARTER 2008 FINANCIAL RESULTS
    (Also in PDF format)
    October 30, 2008
    NOTICE OF PALADIN LABS' THIRD QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    September 25, 2008
    PALADIN TO PRESENT AT BIOCONTACT CONFERENCE IN QUEBEC CITY
    (Also in PDF format)
    September 19, 2008
    PALADIN TO PRESENT AT THE UBS GLOBAL LIFE SCIENCE CONFERENCE IN NEW YORK
    (Also in PDF format)
    September 17, 2008
    PALADIN TO PRESENT AT CIBC WORLD MARKETS 7TH ANNUAL EASTERN INSTITUTIONAL INVESTOR CONFERENCE
    (Also in PDF format)
    August 7, 2008
    PALADIN REPORTS 2008 SECOND QUARTER FINANCIAL RESULTS
    (Also in PDF format)
    July 31, 2008
    NOTICE OF PALADIN LABS' SECOND QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    July 8, 2008
    NUVO RESEARCH AND PALADIN ANNOUNCE AMENDMENTS TO PENNSAID AND PENNSAID PLUS AGREEMENTS
    (Also in PDF format)
    July 2, 2008
    PALADIN LABS AND PROCTER & GAMBLE PHARMACEUTICALS ENTER INTO CANADIAN CO-PROMOTION AGREEMENT FOR SEASONALE(TM): FIRST AND ONLY EXTENDED-CYCLE ORAL CONTRACEPTIVE AVAILABLE IN CANADA
    June 3, 2008
    PALADIN LABS INC.: NEW IMPROVED DOSING APPROVED FOR PENNSAID(R)
    (Also in PDF format)
    May 29, 2008
    NUVO LICENSES TOPICAL PAIN PRODUCT FROM PALADIN
    (Also in PDF format)
    May 15, 2008
    PALADIN LABS INC.: PLAN B(R) EMERGENCY CONTRACEPTIVE NOW OVER THE COUNTER IN CANADA
    (Also in PDF format)
    May 15, 2008
    PALADIN REPORTS 2008 FIRST QUARTER FINANCIAL RESULTS
    May 8, 2008
    NOTICE OF PALADIN LABS' FIRST QUARTER RESULTS CONFERENCE CALL
    (Also in PDF format)
    April 14, 2008
    PALADIN LABS INC.: CANADIAN WOMEN TO BE GRANTED EASIER ACCESS TO EMERGENCY CONTRACEPTION
    (Also in PDF format)
    April 1, 2008
    AETERNA ZENTARIS AND PALADIN LABS COMPLETE SALE AND PURCHASE OF MILTEFOSINE RIGHTS
    (Also in PDF format)
    March 3, 2008
    AETERNA ZENTARIS AND PALADIN LABS ANNOUNCE SALE AND PURCHASE OF MILTEFOSINE RIGHTS
    (Also in PDF format)
    February 29, 2008
    PALADIN FILES NEW DRUG SUBMISSION FOR SEASONIQUE(R)
    (Also in PDF format)
    February 28, 2008
    PALADIN ANNOUNCES NORMAL COURSE ISSUER BID
    (Also in PDF format)
    February 28, 2008
    PALADIN REPORTS RECORD 2007 FOURTH QUARTER AND YEAR END RESULTS
    (Also in PDF format)
    February 21, 2008
    NOTICE OF PALADIN LABS' FOURTH QUARTER AND 2007 YEAR-END RESULTS CONFERENCE CALL
    (Also in PDF format)
    February 19, 2008
    PALADIN TO PRESENT AT THE ROTH CAPITAL PARTNERS 20TH ANNUAL OC GROWTH STOCK CONFERNCE
    (Also in PDF format)
    February 18, 2008
    PALADIN LABS & KV PHARMACEUTICALS SIGN DISTRIBUTION FOR MICRO-K(R) EXTENCAPS(R) CAPSULES
    (Also in PDF format)
    January 31, 2008
    PALADIN AND NYCOMED ENTER INTO CANADIAN CO-PROMOTION AGREEMENT FOR TRIDURAL(TM) ONCE-DAILY TRAMADOL PRODUCT
    (Also in PDF format)
    January 4, 2008
    PALADIN LABS ANNOUNCES SEASONALE LAUNCH
    (Also in PDF format)




    HOME | SITE MAP | LEGAL DISCLAIMER